Cargando…

Chronic Cholestatic Liver Injury Attributable to Vedolizumab

Drug-induced liver injury is a rare but clinically important diagnosis. Vedolizumab is an α4β7 integrin inhibitor recently approved for use in patients with moderate-to-severe inflammatory bowel disease. Cases of hepatoxicity due to vedolizumab in the pre-marketing stage were rare, and all cases res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stine, Jonathan G., Wang, Jennifer, Behm, Brian W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075012/ https://www.ncbi.nlm.nih.gov/pubmed/27777897 http://dx.doi.org/10.14218/JCTH.2016.00018

Ejemplares similares

Dabigatran etexilate: Cholestatic liver injury: case report
Publicado: (2021)

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019)

A rare case of cefepime-induced cholestatic liver injury
por: Liao, Pei-Fei, et al.
Publicado: (2019)

Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma
por: Kurokawa, Kana, et al.
Publicado: (2019)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19
por: Yamazaki, Shingo, et al.
Publicado: (2021)

The Efficacy of Albumin Dialysis in the Treatment of Severe Cholestatic Drug-Induced Liver Injury
por: Narayanan, Mechu, et al.
Publicado: (2022)

Cholestatic Liver Injury in a Patient with Tertiary Syphilis
por: Mujumdar, Sahaj, et al.
Publicado: (2022)

Cellular crosstalk during cholestatic liver injury
por: Thomson, Joanne, et al.
Publicado: (2017)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021)

Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
por: Nayudu, Suresh Kumar, et al.
Publicado: (2013)

Vedolizumab-Associated Hypereosinophilia and Hepatoxicity
por: De Marco, Davide, et al.
Publicado: (2022)

Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab
por: Yeh, Jennifer E., et al.
Publicado: (2017)

Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
por: Ahmadi, Ali R., et al.
Publicado: (2020)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Evaluation and Management of Chronic Cholestatic Liver Diseases
por: Rini, Sandra Surya, et al.
Publicado: (2023)

Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
por: Poli, Antoine, et al.
Publicado: (2023)

Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report
por: Gandhi, Darshan, et al.
Publicado: (2020)

Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Trifluoperazine-Induced Cholestatic Jaundice
por: Sharifi, Vandad, et al.
Publicado: (2010)

Cephalexin Induced Cholestatic Jaundice
por: Agrawal, Abhinav, et al.
Publicado: (2014)

Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017)

Protective Effects of Guava Pulp on Cholestatic Liver Injury
por: Peng, Jian, et al.
Publicado: (2013)

Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

A Case of Evan's Syndrome Induced by Vedolizumab
por: Jen, Henry, et al.
Publicado: (2019)

Vedolizumab Therapy in Refractory Enteropathy Associated With CVID
por: Johnson, Dane, et al.
Publicado: (2021)

PPARα activation protects against cholestatic liver injury
por: Zhao, Qi, et al.
Publicado: (2017)

Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
por: Zeng, Jinhui, et al.
Publicado: (2021)

Fatal Cholestatic Liver Injury during Treatment with PD1 Immune Checkpoint Inhibitor for Malignant Melanoma: A Case Report
por: Thorsteinsdottir, Thuridur, et al.
Publicado: (2020)

Cholestatic hepatitis due to Salmonella typhi
por: Albayrak, Ayse, et al.
Publicado: (2011)

Cholestatic presentation of yellow phosphorus poisoning
por: Lakshmi, C. P., et al.
Publicado: (2014)

Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure
por: Waksman, Ori, et al.
Publicado: (2022)

Adalimumab/vedolizumab: Gastroparesis and COVID infection: case report
Publicado: (2021)

Vedolizumab-Induced Acute Interstitial Nephritis in Ulcerative Colitis
por: Subhaharan, Deloshaan, et al.
Publicado: (2022)

Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury
por: Gao, Xingjuan, et al.
Publicado: (2020)

Severe Cholestatic Drug-Induced Liver Injury With Cephalosporin Use
por: Yang, Kevin, et al.
Publicado: (2022)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
por: Nishio, Takahiro, et al.
Publicado: (2022)

Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review
por: Saadi, Tarek, et al.
Publicado: (2013)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
por: Min, Jianbin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_khmf27c3kt11c9asqegcpvtp6l